Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming-Lung Yu

Showing results (311-320 of 527) with videos related to

Pageof 53
Sort By:
Antiviral Therapy|August 6, 2011
Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapyTai-Chung Tseng, Ming-Lung Yu, Chun-Jen Liu, et al.
Oncotarget|April 22, 2017
Diversity of the association of serum levels and genetic variants of MHC class I polypeptide-related chain A with liver fibrosis in chronic hepatitis CChung-Feng Huang, Ching-I Huang, Ming-Lun Yeh, et al.
The Kaohsiung Journal of Medical Sciences|August 3, 2013
Association between gallbladder stones and chronic hepatitis C: ultrasonographic survey in a hepatitis C and B hyperendemic township in TaiwanChia-Yen Dai, Chia-I Lin, Ming-Lun Yeh, et al.
Microbiology Spectrum|May 17, 2022
Performance of Hepatitis C Virus (HCV) Core Antigen Assay in the Diagnosis of Recently Acquired HCV Infection among High-Risk PopulationsHsin-Yun Sun, Wang-Da Liu, Chih-Wen Wang, et al.
International Journal of Molecular Sciences|July 17, 2020
Clusters of Circulating let-7 Family Tumor Suppressors Are Associated with Clinical Characteristics of Chronic Hepatitis CYi-Shan Tsai, Ming-Lun Yeh, Pei-Chien Tsai, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|November 4, 2017
The treatment outcome and impact on blood transfusion demand of Peg-interferon/ribavirin in thalassemic patients with chronic hepatitis CPo-Cheng Liang, Pei-Chin Lin, Ching-I Huang, et al.
Plos One|September 15, 2015
Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected PatientsChi-Chieh Yang, Wei-Lun Tsai, Wei-Wen Su, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 16, 2024
Chronic Viral Hepatitis B and C Outweigh MASLD in the Associated Risk of Cirrhosis and HCCMei-Hsuan Lee, Yi-Ting Chen, Yu-Han Huang, et al.
Journal of Clinical Lipidology|April 9, 2016
Nonalcoholic fatty liver disease severity is associated with the ratios of total cholesterol and triglycerides to high-density lipoprotein cholesterolKuan-Ta Wu, Po-Lin Kuo, Shih-Bin Su, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 21, 2020
Exosome-derived differentiation antagonizing non-protein coding RNA with risk of hepatitis C virus-related hepatocellular carcinoma recurrenceShu-Chi Wang, Chia-Yang Li, Wen-Tsan Chang, et al.
Pageof 53

Showing results (311-320 of 527) with videos related to

Sort By:
Pageof 53
Antiviral Therapy|August 6, 2011
Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapyTai-Chung Tseng, Ming-Lung Yu, Chun-Jen Liu, et al.
Oncotarget|April 22, 2017
Diversity of the association of serum levels and genetic variants of MHC class I polypeptide-related chain A with liver fibrosis in chronic hepatitis CChung-Feng Huang, Ching-I Huang, Ming-Lun Yeh, et al.
The Kaohsiung Journal of Medical Sciences|August 3, 2013
Association between gallbladder stones and chronic hepatitis C: ultrasonographic survey in a hepatitis C and B hyperendemic township in TaiwanChia-Yen Dai, Chia-I Lin, Ming-Lun Yeh, et al.
Microbiology Spectrum|May 17, 2022
Performance of Hepatitis C Virus (HCV) Core Antigen Assay in the Diagnosis of Recently Acquired HCV Infection among High-Risk PopulationsHsin-Yun Sun, Wang-Da Liu, Chih-Wen Wang, et al.
International Journal of Molecular Sciences|July 17, 2020
Clusters of Circulating let-7 Family Tumor Suppressors Are Associated with Clinical Characteristics of Chronic Hepatitis CYi-Shan Tsai, Ming-Lun Yeh, Pei-Chien Tsai, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|November 4, 2017
The treatment outcome and impact on blood transfusion demand of Peg-interferon/ribavirin in thalassemic patients with chronic hepatitis CPo-Cheng Liang, Pei-Chin Lin, Ching-I Huang, et al.
Plos One|September 15, 2015
Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected PatientsChi-Chieh Yang, Wei-Lun Tsai, Wei-Wen Su, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 16, 2024
Chronic Viral Hepatitis B and C Outweigh MASLD in the Associated Risk of Cirrhosis and HCCMei-Hsuan Lee, Yi-Ting Chen, Yu-Han Huang, et al.
Journal of Clinical Lipidology|April 9, 2016
Nonalcoholic fatty liver disease severity is associated with the ratios of total cholesterol and triglycerides to high-density lipoprotein cholesterolKuan-Ta Wu, Po-Lin Kuo, Shih-Bin Su, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 21, 2020
Exosome-derived differentiation antagonizing non-protein coding RNA with risk of hepatitis C virus-related hepatocellular carcinoma recurrenceShu-Chi Wang, Chia-Yang Li, Wen-Tsan Chang, et al.
Pageof 53